Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
L-arginine + proanthocyanidine + L-glutathione is a combination nutritional supplement developed and marketed by Novogen Captab. The formulation combines three active ingredients to support vascular health and improve blood circulation. **L-arginine** is an amino acid that serves as a precursor for nitric oxide synthesis, acting as a vasodilator to relax and expand blood vessels. **Proanthocyanidine**, typically extracted from grape seeds, is a polyphenolic antioxidant that reduces oxidative stress and inflammation within the vasculature. **L-glutathione** is a tripeptide antioxidant that helps protect nitric oxide from oxidative degradation, thereby enhancing its bioavailability and functional effect. This combination is primarily indicated for conditions associated with vascular dysfunction, including pre-eclampsia, intrauterine growth restriction (IUGR), hypertension, diabetes-related vascular complications, and erectile dysfunction. It is approved for use as a dietary supplement in India.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on l-arginine + proanthocyanidine + l-glutathione.